Mission Produce (AVO) Down 6.8% Since Last Earnings Report: Can It Rebound?

Mission Produce reported fiscal Q3 2026 revenue of $450 million, up 25.8% year over year and 22.3% above consensus, while adjusted EPS of $0.18 beat the $0.10 estimate but declined from $0.26 a year earlier. Adjusted EBITDA was $32.4 million, above the high end of guidance, but gross margin contracted 270 basis points to 9.9% as avocado prices faced supply pressure; shares had fallen 6.8% since the report. Management reaffirmed second-half adjusted EBITDA guidance of $84 million to $88 million and raised its annualized Calavo synergy target to more than $30 million from at least $25 million.

Analysis

The key debate is earnings quality, not the beat: acquired volume can lift reported sales while industry oversupply pressures realized pricing, and AVO’s lower-margin farming exposure makes volume growth an unreliable proxy for profit growth. Retail demand and market-share gains offer a useful buffer, but do not by themselves establish pricing power. The near-term setup is asymmetric around execution: Q4 guidance depends on Peru sales arriving in the expected window, seasonal blueberry contribution, and improved avocado margins. A miss in any one can expose how much of the expected step-up is seasonal versus repeatable.

Over 1–3 months, watch Q4 EBITDA against the $52–55 million guide, segment margins, and operating cash flow—not just revenue or adjusted EPS. The 6–18 month question is whether Calavo synergies exceed the acquired business’s added overhead and integration burden. Higher debt and weaker year-to-date cash generation raise the value of proof that synergies translate into cash, particularly if pricing stays soft. The stock’s post-report weakness despite upward estimate revisions may reflect skepticism about durability; it is not, on its own, evidence of mispricing. The bullish thesis fails if Q4 EBITDA misses guidance, farming margins deteriorate, or cash conversion remains weak as integration costs fade.

Key Decisions for Investors

• Keep AVO on a conditional long watch rather than chase the estimate revisions. Consider initiating only after Q4 results demonstrate delivery near the $52–55 million EBITDA range and show margin improvement; size conservatively until cash conversion confirms the earnings improvement.
• For the next earnings event, track realized avocado prices and segment adjusted EBITDA alongside pounds sold. Rising volume with weaker gross profit or continued farming-margin pressure would falsify the operating-leverage thesis and argue against adding exposure.
• Treat the >$30 million annualized Calavo synergy goal as an unverified catalyst, not current earnings power. Reassess through fiscal 2027 using reported savings net of integration/overhead and operating cash flow; a shortfall or persistent cash use would invalidate the rerating case.
• No standalone CVGW trade is supported by the supplied facts. Avoid using the acquisition contribution as a proxy for CVGW’s independent outlook; verify post-transaction reporting and any remaining public-company exposure before expressing a view.